The purpose of this transmittal is to notify all District Fee-for-Service (FFS) Medicaid providers that the Department of Health Care Finance (DHCF) is expanding providers’ drug acquisition options for Physician-Administered Non-Chemotherapy Injectable Medical Benefit Drugs. This transmittal defines, clarifies, and informs health care providers about the process of acquiring and billing for Physician-Administered Non-Chemotherapy Injectable Medical Benefit Drugs. This change will allow providers to use “White Bagging” in addition to the “Buy & Bill” policy.